We are live on ! Find out more
PI

Putnam Investments Portfolio holdings

AUM $75.7B
1-Year Est. Return 34.45%
This Fund
S&P 500
This Quarter Est. Return
-1.39%
1 Year Est. Return
+34.45%
3 Year Est. Return
+61.95%
5 Year Est. Return
+203.43%
10 Year Est. Return
+442.91%
AUM
$42.1B
AUM Growth
-$2.17B
Cap. Flow
-$945M
Cap. Flow %
-2.25%
Top 10 Hldgs %
21.19%
Holding
1,551
New
109
Increased
575
Reduced
561
Closed
157

Sector Composition

Rank Sector Weight
1 Healthcare 19.21%
2 Communication Services 14.45%
3 Financials 11.34%
4 Technology 10.67%
5 Industrials 9.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
POWI icon
901
Power Integrations
POWI
$3.61B
$1.81M ﹤0.01%
72,952
+1,500
+2% +$34.5K
BIG
902
DELISTED
Big Lots, Inc.
BIG
$1.81M ﹤0.01%
40,016
+779
+2% +$31.2K
AGCO icon
903
AGCO
AGCO
$7.2B
$1.81M ﹤0.01%
36,442
-126,224
-78% -$6.07M
FDS icon
904
Factset
FDS
$10.2B
$1.81M ﹤0.01%
11,933
-62,654
-84% -$9.35M
WELL icon
905
Welltower
WELL
$171B
$1.79M ﹤0.01%
25,755
-2,008
-7% -$129K
LNG icon
906
Cheniere Energy
LNG
$52.9B
$1.78M ﹤0.01%
+52,762
New +$1.71M
SGRY icon
907
Surgery Partners
SGRY
$2.03B
$1.77M ﹤0.01%
133,821
+22,784
+21% +$352K
SUPN icon
908
Supernus Pharmaceuticals
SUPN
$2.77B
$1.77M ﹤0.01%
115,806
+38,284
+49% +$500K
CATO icon
909
Cato Corp
CATO
$66.1M
$1.76M ﹤0.01%
45,741
-650
-1% -$23.9K
LHCG
910
DELISTED
LHC Group LLC
LHCG
$1.74M ﹤0.01%
49,025
-965
-2% -$35.5K
BIO icon
911
Bio-Rad Laboratories Class A
BIO
$9.42B
$1.74M ﹤0.01%
12,735
-878
-6% -$115K
EGBN icon
912
Eagle Bancorp
EGBN
$845M
$1.69M ﹤0.01%
35,289
OXM icon
913
Oxford Industries
OXM
$552M
$1.69M ﹤0.01%
25,138
+482
+2% +$32.8K
WAGE
914
DELISTED
WageWorks, Inc.
WAGE
$1.69M ﹤0.01%
33,292
+8,965
+37% +$402K
VCO
915
DELISTED
Vina Concha Y Toro 50 Shrs
VCO
$1.69M ﹤0.01%
+48,725
New +$1.56M
ARLZ
916
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$1.68M ﹤0.01%
+472,765
New +$2.44M
STE icon
917
Steris
STE
$23.1B
$1.67M ﹤0.01%
23,553
+492
+2% +$33.3K
SYNA icon
918
Synaptics
SYNA
$4.15B
$1.67M ﹤0.01%
20,893
-14,753
-41% -$1.12M
LGND icon
919
Ligand Pharmaceuticals
LGND
$6.36B
$1.65M ﹤0.01%
24,720
+497
+2% +$30.2K
HTGM
920
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$1.65M ﹤0.01%
3,187
-11
-0.3% -$6.15K
MT icon
921
ArcelorMittal
MT
$55.3B
$1.64M ﹤0.01%
+119,706
New +$1.16M
SEMI
922
DELISTED
SunEdison Semiconductor Limited
SEMI
$1.64M ﹤0.01%
+253,287
New +$1.52M
MMS icon
923
Maximus
MMS
$3.1B
$1.63M ﹤0.01%
30,994
+645
+2% +$32.9K
ASXC
924
DELISTED
Asensus Surgical, Inc.
ASXC
$1.63M ﹤0.01%
29,431
-9,900
-25% -$424K
CCP
925
DELISTED
Care Capital Properties, Inc.
CCP
$1.62M ﹤0.01%
+60,334
New +$1.67M

Similar funds

Putnam Investments's Q1 2016 Portfolio in Review

As of Q1 2016, Putnam Investments held 1,551 positions worth $42.1B, down 4.9% from $44.3B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Putnam Investments's Q1 2016 filing shows 109 new, 575 increased, 561 reduced and 157 closed positions. Its largest new stake was State Street Consumer Staples Select Sector SPDR ETF: 669,760 shares worth $35.5M. The largest sale was Raytheon Company, an estimated $271M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 21% a quarter earlier, followed by Communication Services and Financials.

  • Putnam Investments's largest Q1 2016 buy was State Street Consumer Staples Select Sector SPDR ETF: 669,760 shares worth $35.5M.
  • Putnam Investments added most to Becton Dickinson in Q1 2016, an estimated $137M increase.
  • Putnam Investments's biggest Q1 2016 reduction was Raytheon Company, cutting an estimated $271M.
  • Putnam Investments fully exited MPLX in Q1 2016, selling an estimated $34.3M.
  • Putnam Investments's ten largest holdings make up 21% of its $42.1B portfolio in Q1 2016.
  • Putnam Investments opened 109 new positions and closed 157 in Q1 2016.
  • Putnam Investments's portfolio value fell 4.9% quarter-over-quarter to $42.1B.

Based on Putnam Investments's 13F filing for Q1 2016, filed 16 May 2016.